Community-acquired pneumonia and COPD: what do we know?

Symposium
Chairs: A. Torres (Barcelona, Spain), B. Balbi (Veruno, Italy)
Aims: This symposium will describe the interaction and impact of COPD and community-acquired pneumonia (CAP).

Community-acquired pneumonia: impact of COPD A. Anzueto (San Antonio, Tx, United States of America)
COPD: what is the frequency and impact of community-acquired pneumonia? M. Woodhead (Manchester, United Kingdom)
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? T. Welte (Hanover, Germany)